News Conference News EAS 2018 ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran Yael L. Maxwell May 14, 2018
News Conference News EAS 2018 Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction Yael L. Maxwell May 08, 2018
News Conference News EAS 2018 Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention Yael L. Maxwell May 07, 2018
News Daily News LPA Variants Linked With CHD Events in Statin-Treated Patients Michael O'Riordan May 03, 2018
News Daily News The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis Michael O'Riordan April 20, 2018
News Daily News Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes Shelley Wood April 18, 2018
News Daily News Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say Michael O'Riordan April 09, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2018 Shelley Wood April 02, 2018
News Industry News Amgen Receives Positive CHMP Opinion Recognizing That Repatha® (evolocumab) Prevents Heart Attacks And Strokes March 23, 2018
News Conference News ACC 2018 High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab Michael O'Riordan March 20, 2018
News Conference News ACC 2018 ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit Michael O'Riordan March 10, 2018
News Conference News ACC 2018 ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins Shelley Wood March 10, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Daily News Nonstatin Use and Expenditures Are Up Despite the Dearth of Evidence Supporting Efficacy Yael L. Maxwell January 29, 2018
News Daily News Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers Yael L. Maxwell January 24, 2018
News Daily News Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward Michael O'Riordan January 09, 2018
Presentation Controversies and Advances 2017 PCSK9 Inhibitors - Are They Worth The Money? Presenter: Michael J. Blaha November 16, 2017